$MHO
M/I HOMES, INC. Stock $mho

$mho Overview Financials Valuation SEC Filings Company Website

2020 Q2 Form 10-Q Financial Statement

#000079929220000081 Filed on July 31, 2020

Income Statement

Concept	2020 Q2	2019 Q2
Revenue	$714.2M	$623.7M
YoY Change	14.51%	11.75%
Cost Of Revenue	$557.8M	$503.9M
YoY Change	10.7%	12.14%
Gross Profit	$156.4M	$119.8M
YoY Change	30.52%	10.18%
Gross Profit Margin	21.9%	19.21%
Selling, General & Admin	$82.16M	$73.62M
YoY Change	11.61%	4.78%
% of Gross Profit	52.53%	61.43%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.600M	$3.300M
YoY Change	9.09%	17.86%
% of Gross Profit	2.3%	2.75%
Operating Expenses	$82.16M	$73.62M
YoY Change	11.61%	4.78%
Operating Profit	$74.24M	$46.21M
YoY Change	60.65%	20.02%
Interest Expense	$2.515M	$5.197M
YoY Change	-51.61%	6.32%
% of Operating Profit	3.39%	11.25%
Other Income/Expense, Net
YoY Change
Pretax Income	$71.73M	$41.20M
YoY Change	74.08%	22.88%
Income Tax	$17.20M	$10.96M
% Of Pretax Income	23.98%	26.59%
Net Earnings	$54.51M	$30.25M
YoY Change	80.22%	8.37%
Net Earnings / Revenue	7.63%	4.85%
Basic Earnings Per Share	$1.91	$1.10
Diluted Earnings Per Share	$1.89	$1.08
COMMON SHARES
Basic Shares Outstanding	28.53M shares	27.60M shares
Diluted Shares Outstanding	28.84M shares	28.09M shares

Balance Sheet

Concept	2020 Q2	2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$94.00M	$20.40M
YoY Change	360.78%	-69.91%
Cash & Equivalents	$94.02M	$20.39M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory	$1.831B	$1.764B
Prepaid Expenses
Receivables	$163.5M	$123.9M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$2.088B	$1.908B
YoY Change	9.46%	4.35%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.00M	$28.09M
YoY Change	-25.24%	-2.74%
Goodwill	$16.40M	$16.40M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments	$45.14M	$41.34M
YoY Change	9.19%	200.62%
Other Assets	$9.400M	$12.60M
YoY Change	-25.4%	-28.0%
Total Long-Term Assets	$239.4M	$181.4M
YoY Change	31.97%	27.54%
TOTAL ASSETS
Total Short-Term Assets	$2.088B	$1.908B
Total Long-Term Assets	$239.4M	$181.4M
Total Assets	$2.328B	$2.089B
YoY Change	11.42%	6.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$169.1M	$154.1M
YoY Change	9.73%	8.9%
Accrued Expenses	$51.20M	$19.40M
YoY Change	163.92%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$269.8M	$211.5M
YoY Change	27.57%	15.57%
LONG-TERM LIABILITIES
Long-Term Debt	$782.8M	$828.7M
YoY Change	-5.54%	0.08%
Other Long-Term Liabilities	$180.7M	$144.8M
YoY Change	24.79%	0.84%
Total Long-Term Liabilities	$963.5M	$973.5M
YoY Change	-1.03%	0.2%
TOTAL LIABILITIES
Total Short-Term Liabilities	$269.8M	$211.5M
Total Long-Term Liabilities	$963.5M	$973.5M
Total Liabilities	$1.233B	$1.185B
YoY Change	4.08%	2.63%
SHAREHOLDERS EQUITY
Retained Earnings	$794.8M	$629.0M
YoY Change	26.37%	21.12%
Common Stock	$334.6M	$330.4M
YoY Change	1.27%	0.79%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$34.99M	$55.07M
YoY Change	-36.47%	77.04%
Treasury Stock Shares	1.594M shares	2.520M shares
Shareholders Equity	$1.094B	$904.2M
YoY Change
Total Liabilities & Shareholders Equity	$2.328B	$2.089B
YoY Change	11.42%	6.02%

Cashflow Statement

Concept	2020 Q2	2019 Q2
OPERATING ACTIVITIES
Net Income	$54.51M	$30.25M
YoY Change	80.22%	8.37%
Depreciation, Depletion And Amortization	$3.600M	$3.300M
YoY Change	9.09%	17.86%
Cash From Operating Activities	$107.0M	$33.20M
YoY Change	222.29%	188.7%
INVESTING ACTIVITIES
Capital Expenditures	-$1.500M	-$1.100M
YoY Change	36.36%	-75.56%
Acquisitions
YoY Change
Other Investing Activities	-$12.60M	-$9.100M
YoY Change	38.46%	355.0%
Cash From Investing Activities	-$14.20M	-$10.20M
YoY Change	39.22%	59.38%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-20.10M	-44.50M
YoY Change	-54.83%	-583.7%
NET CHANGE
Cash From Operating Activities	107.0M	33.20M
Cash From Investing Activities	-14.20M	-10.20M
Cash From Financing Activities	-20.10M	-44.50M
Net Change In Cash	72.70M	-21.50M
YoY Change	-438.14%	-250.35%
FREE CASH FLOW
Cash From Operating Activities	$107.0M	$33.20M
Capital Expenditures	-$1.500M	-$1.100M
Free Cash Flow	$108.5M	$34.30M
YoY Change	216.33%	114.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0000799292
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Amendment Flag AmendmentFlag	false
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1593512	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1750685	shares
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	55000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	66000	USD
CY2020Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q2	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2019Q2	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2019Q4	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	0	USD
CY2020Q2	mho	Loan Repurchase Guarantee Liability LoanRepurchaseGuaranteeLiability	500000	USD
CY2019Q4	mho	Loan Repurchase Guarantee Liability LoanRepurchaseGuaranteeLiability	500000	USD
CY2020Q2	mho	Total Of Guaranteed Loans Inquired About TotalOfGuaranteedLoansInquiredAbout	600000	USD
CY2019Q4	mho	Total Of Guaranteed Loans Inquired About TotalOfGuaranteedLoansInquiredAbout	600000	USD
CY2020Q2	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.97	Rate
CY2019Q2	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.98	Rate
	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.97	Rate
	mho	Homebuildingoperationspercentoftotalrevenue Homebuildingoperationspercentoftotalrevenue	0.98	Rate
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Entity File Number EntityFileNumber	1-12434
	dei	Document Period End Date DocumentPeriodEndDate	2020-06-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	M/I HOMES, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	OH
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	31-1210837
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4131 Worth Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 500
	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbus
	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43219
	dei	City Area Code CityAreaCode	614
	dei	Local Phone Number LocalPhoneNumber	418-8000
	dei	Security12b Title Security12bTitle	Common Shares, par value $.01
	dei	Trading Symbol TradingSymbol	MHO
	dei	Security Exchange Name SecurityExchangeName	NYSE
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	28543629	shares
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94023000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6083000	USD
CY2020Q2	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	163536000	USD
CY2019Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	155244000	USD
CY2020Q2	us-gaap	Inventory Real Estate InventoryRealEstate	1830810000	USD
CY2019Q4	us-gaap	Inventory Real Estate InventoryRealEstate	1769507000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21004000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22118000	USD
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	45144000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	37885000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51193000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18415000	USD
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9378000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9631000	USD
CY2020Q2	us-gaap	Goodwill Goodwill	16400000	USD
CY2019Q4	us-gaap	Goodwill Goodwill	16400000	USD
CY2020Q2	us-gaap	Other Assets OtherAssets	96220000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	70311000	USD
CY2020Q2	us-gaap	Assets Assets	2327708000	USD
CY2019Q4	us-gaap	Assets Assets	2105594000	USD
CY2020Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	169088000	USD
CY2019Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	125026000	USD
CY2020Q2	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	49529000	USD
CY2019Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	34462000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	51193000	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18415000	USD
CY2020Q2	us-gaap	Other Liabilities OtherLiabilities	158146000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	147937000	USD
CY2020Q2	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	11560000	USD
CY2019Q4	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	13531000	USD
CY2020Q2	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	11035000	USD
CY2019Q4	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	7934000	USD
CY2020Q2	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2019Q4	us-gaap	Line Of Credit LineOfCredit	66000000	USD
CY2020Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	134184000	USD
CY2019Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	136904000	USD
CY2020Q2	us-gaap	Other Notes Payable OtherNotesPayable	7041000	USD
CY2019Q4	us-gaap	Other Notes Payable OtherNotesPayable	5828000	USD
CY2020Q2	mho	Seniornotesdue2021 Seniornotesdue2021	0	USD
CY2019Q4	mho	Seniornotesdue2021 Seniornotesdue2021	298988000	USD
CY2020Q2	mho	Seniornotesdue2025 Seniornotesdue2025	247353000	USD
CY2019Q4	mho	Seniornotesdue2025 Seniornotesdue2025	247092000	USD
CY2020Q2	mho	Seniornotesdue2028 Seniornotesdue2028	394174000	USD
CY2019Q4	mho	Seniornotesdue2028 Seniornotesdue2028	0	USD
CY2020Q2	us-gaap	Liabilities Liabilities	1233303000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1102117000	USD
CY2020Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies	0	USD
CY2020Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	58000000	shares
CY2020Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30137141	shares
CY2020Q2	us-gaap	Common Stock Value CommonStockValue	301000	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	301000	USD
CY2020Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	334261000	USD
CY2019Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	332861000	USD
CY2020Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	794833000	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	708579000	USD
CY2020Q2	us-gaap	Treasury Stock Shares TreasuryStockShares	1593512	shares
CY2019Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	1750685	shares
CY2020Q2	us-gaap	Treasury Stock Value TreasuryStockValue	34990000	USD
CY2019Q4	us-gaap	Treasury Stock Value TreasuryStockValue	38264000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1094405000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1003477000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2327708000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2105594000	USD
CY2020Q2	us-gaap	Revenues Revenues	714194000	USD
CY2019Q2	us-gaap	Revenues Revenues	623686000	USD
	us-gaap	Revenues Revenues	1291797000	USD
	us-gaap	Revenues Revenues	1104795000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	557791000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	503857000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1018715000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	892324000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41037000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36164000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	74884000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66863000	USD
CY2020Q2	us-gaap	Selling Expense SellingExpense	41127000	USD
CY2019Q2	us-gaap	Selling Expense SellingExpense	37452000	USD
	us-gaap	Selling Expense SellingExpense	77955000	USD
	us-gaap	Selling Expense SellingExpense	69003000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	187000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	55000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	66000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	2515000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	5197000	USD
	us-gaap	Interest Expense InterestExpense	7215000	USD
	us-gaap	Interest Expense InterestExpense	11989000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	642467000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	582483000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1178714000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1040113000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71727000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41203000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	113083000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	64682000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17219000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10957000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26829000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16713000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	54508000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	30246000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86254000	USD
	us-gaap	Net Income Loss NetIncomeLoss	47969000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.91
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.74
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.89
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28531000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27599000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28504000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27549000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28836000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28090000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28920000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28027000	shares
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1037681000	USD
CY2020Q2	us-gaap	Profit Loss ProfitLoss	54508000	USD
CY2020Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	463000	USD
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1753000	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1094405000	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1003477000	USD
	us-gaap	Profit Loss ProfitLoss	86254000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3645000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2726000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1912000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	215000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	0	USD
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1094405000	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	871462000	USD
CY2019Q2	us-gaap	Profit Loss ProfitLoss	30246000	USD
CY2019Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	849000	USD
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1682000	USD
CY2019Q2	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	1000	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	904240000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	855303000	USD
	us-gaap	Profit Loss ProfitLoss	47969000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3277000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2594000	USD
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5150000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	247000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Distribution Paid DeferredCompensationArrangementWithIndividualDistributionPaid	0	USD
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	904240000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86254000	USD
	us-gaap	Net Income Loss NetIncomeLoss	47969000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	55000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	66000	USD
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	773970000	USD
	us-gaap	Payments For Origination Of Mortgage Loans Held For Sale PaymentsForOriginationOfMortgageLoansHeldForSale	570989000	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	766105000	USD
	us-gaap	Proceeds From Sale Of Mortgage Loans Held For Sale ProceedsFromSaleOfMortgageLoansHeldForSale	615714000	USD
	mho	Fair Value Adjustment Of Mortgage Loans Held For Sale FairValueAdjustmentOfMortgageLoansHeldForSale	427000	USD
	mho	Fair Value Adjustment Of Mortgage Loans Held For Sale FairValueAdjustmentOfMortgageLoansHeldForSale	-1017000	USD
	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	422000	USD
	us-gaap	Servicing Asset At Fair Value Period Increase Decrease ServicingAssetAtFairValuePeriodIncreaseDecrease	0	USD
	us-gaap	Payments For Proceeds From Mortgage Servicing Rights PaymentsForProceedsFromMortgageServicingRights	2233000	USD
	us-gaap	Payments For Proceeds From Mortgage Servicing Rights PaymentsForProceedsFromMortgageServicingRights	1588000	USD
	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	1159000	USD
	us-gaap	Amortization Of Mortgage Servicing Rights Ms Rs AmortizationOfMortgageServicingRightsMSRs	657000	USD
	us-gaap	Depreciation Depreciation	6037000	USD
	us-gaap	Depreciation Depreciation	5698000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1228000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1352000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	950000	USD
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2726000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	2594000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-253000	USD
	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-888000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	51603000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	89853000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20753000	USD
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-240000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	44062000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	22560000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	15067000	USD
	us-gaap	Increase Decrease In Customer Deposits IncreaseDecreaseInCustomerDeposits	5993000	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-16699000	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-18486000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	24303000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-13083000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	82826000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10617000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1976000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1599000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	363000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	150000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	19089000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	15281000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20702000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16730000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	300000000	USD
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	0	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	400000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	0	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	306800000	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	374500000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	372800000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	317600000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-2720000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-49165000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	1213000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-845000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	13557000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1912000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5150000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8410000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	40000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3645000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3277000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25816000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4977000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	87940000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1136000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6083000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21529000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94023000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20393000	USD
	us-gaap	Interest Paid Net InterestPaidNet	6114000	USD
	us-gaap	Interest Paid Net InterestPaidNet	10585000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1862000	USD
	mho	Community Development District Infrastructure CommunityDevelopmentDistrictInfrastructure	-1971000	USD
	mho	Community Development District Infrastructure CommunityDevelopmentDistrictInfrastructure	-1526000	USD
	mho	Consolidated Inventory Not Owned Obligation ConsolidatedInventoryNotOwnedObligation	3101000	USD
	mho	Consolidated Inventory Not Owned Obligation ConsolidatedInventoryNotOwnedObligation	-6199000	USD
	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	11522000	USD
	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	9723000	USD
	us-gaap	Basis Of Accounting BasisOfAccounting	Basis of Presentation<div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The accompanying Unaudited Condensed Consolidated Financial Statements (the “financial statements”) of M/I Homes, Inc. and its subsidiaries (the “Company”) and notes thereto have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. The financial statements include the accounts of the Company. All intercompany transactions have been eliminated. Results for the interim period are not necessarily indicative of results for a full year, including as a result of the novel coronavirus (COVID-19) pandemic which has disrupted, and is expected to continue to disrupt, our business. In the opinion of management, the accompanying financial statements reflect all adjustments (all of which are normal and recurring in nature) necessary for a fair presentation of financial results for the interim periods presented. These financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”).</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that period. Actual results could differ from these estimates and have a significant impact on the financial condition and results of operations and cash flows. With regard to the Company, estimates and assumptions are inherent in calculations relating to valuation of inventory and investment in unconsolidated joint ventures, property and equipment depreciation, valuation of derivative financial instruments, accounts payable on inventory, accruals for costs to complete inventory, accruals for warranty claims, accruals for self-insured general liability claims, litigation, accruals for health care and workers’ compensation, accruals for guaranteed or indemnified loans, stock-based compensation expense, income taxes, and contingencies. Items that could have a significant impact on these estimates and assumptions include the risks and uncertainties listed in “Item 1A. Risk Factors” in Part I of our 2019 Form 10-K and in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q, as the same may be updated from time to time in our subsequent filings with the SEC. </span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Recently Adopted Accounting Standards</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to estimate credit losses. ASU 2016-13 is effective for our fiscal year beginning January 1, 2020. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU No. 2018-19, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (“ASU 2018-19”) in November 2018, ASU No. 2019-04, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(“ASU 2019-04”)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">in April 2019, and ASU No. 2019-05, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Financial Instruments-Credit Losses (Topic 326) Targeted Transition Relief </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(“ASU 2019-05”) in May 2019. These ASUs do not change the core principle of the guidance in ASU 2016-13. Instead these amendments are intended to clarify and improve operability of certain topics included within the credit losses standard. These ASUs will have the same effective date and transition requirements as ASU 2016-13. The adoption of ASU 2016-13 on January 1, 2020 did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(“ASU 2018-13”)</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">.</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> ASU 2018-13 modifies the disclosure requirements for fair value measurements and removes the requirement to disclose (1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (2) the policy for timing of transfers between levels, and (3) the valuation processes for Level 3 fair value measurements. ASU 2018-13 requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. For all entities, ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Our adoption of ASU 2018-13 on January 1, 2020 did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">(“ASU 2020-04”). ASU 2020-04 is intended to provide temporary optional expedients and exceptions to the US </span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. This guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The adoption of this guidance did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify;margin-top:10pt;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Impact of New Accounting Standards</span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">In March 2020, the FASB issued ASU No. 2020-03, </span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;">Codification Improvements to Financial Instruments</span><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;"> (“ASU 2020-03”). ASU 2020-03 improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016 (described above). ASU 2020-03 includes seven different issues that describe the areas of improvement and the related amendments to GAAP that are intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;">In May 2020, the SEC adopted Release No.33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses” (the “Final Rule”). The Final Rule is effective on January 1, 2021. However, voluntary early adoption is permitted. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div><span><br/></span></div><div style="text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;">Significant Accounting Policies</span></div><div style="text-align:justify;"><span><br/></span></div><div style="text-align:justify;margin-bottom:10pt;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;">We believe that there have been no significant changes to our significant accounting policies during the quarter ended June 30, 2020 as compared to those disclosed in our 2019 Form 10-K.</span></div>
CY2020Q2	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	843649000	USD
CY2019Q4	us-gaap	Inventory Real Estate Land And Land Development Costs InventoryRealEstateLandAndLandDevelopmentCosts	858065000	USD
CY2020Q2	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	2385000	USD
CY2019Q4	us-gaap	Inventory Land Held For Sale InventoryLandHeldForSale	5670000	USD
CY2020Q2	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	834661000	USD
CY2019Q4	us-gaap	Inventory Homes Under Construction InventoryHomesUnderConstruction	756998000	USD
CY2020Q2	mho	Model Home Accumulated Depreciation ModelHomeAccumulatedDepreciation	14196000	USD
CY2019Q4	mho	Model Home Accumulated Depreciation ModelHomeAccumulatedDepreciation	12723000	USD
CY2020Q2	mho	Inventory Model Homes And Furnishings InventoryModelHomesAndFurnishings	94532000	USD
CY2019Q4	mho	Inventory Model Homes And Furnishings InventoryModelHomesAndFurnishings	98777000	USD
CY2020Q2	mho	Community Development District CommunityDevelopmentDistrict	11560000	USD
CY2019Q4	mho	Community Development District CommunityDevelopmentDistrict	13531000	USD
CY2020Q2	mho	Land Purchase Deposits LandPurchaseDeposits	32988000	USD
CY2019Q4	mho	Land Purchase Deposits LandPurchaseDeposits	28532000	USD
CY2020Q2	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	11035000	USD
CY2019Q4	us-gaap	Land Under Purchase Options Recorded LandUnderPurchaseOptionsRecorded	7934000	USD
CY2020Q2	us-gaap	Inventory Real Estate InventoryRealEstate	1830810000	USD
CY2019Q4	us-gaap	Inventory Real Estate InventoryRealEstate	1769507000	USD
CY2020Q2	mho	Number Of Speculative Homes NumberOfSpeculativeHomes	1181	homes
CY2020Q2	mho	Speculative Homes Carrying Value SpeculativeHomesCarryingValue	210200000	USD
CY2019Q4	mho	Number Of Speculative Homes NumberOfSpeculativeHomes	1459
CY2019Q4	mho	Speculative Homes Carrying Value SpeculativeHomesCarryingValue	304000000.0	USD
CY2020Q2	mho	Community Development District CommunityDevelopmentDistrict	11600000	USD
CY2019Q4	mho	Community Development District CommunityDevelopmentDistrict	13500000	USD
CY2020Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	22199000	USD
CY2019Q1	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	21506000	USD
CY2019Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	21607000	USD
CY2018Q4	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	20765000	USD
CY2020Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	7758000	USD
CY2019Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	8036000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	14920000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Incurred RealEstateInventoryCapitalizedInterestCostsIncurred	14170000	USD
CY2020Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	7754000	USD
CY2019Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	7380000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	14324000	USD
	us-gaap	Real Estate Inventory Capitalized Interest Costs Cost Of Sales1 RealEstateInventoryCapitalizedInterestCostsCostOfSales1	12773000	USD
CY2020Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	22203000	USD
CY2019Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	22162000	USD
CY2020Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	22203000	USD
CY2019Q2	us-gaap	Real Estate Inventory Capitalized Interest Costs RealEstateInventoryCapitalizedInterestCosts	22162000	USD
CY2020Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	10273000	USD
CY2019Q2	us-gaap	Interest Costs Incurred InterestCostsIncurred	13233000	USD
	us-gaap	Interest Costs Incurred InterestCostsIncurred	22135000	USD
	us-gaap	Interest Costs Incurred InterestCostsIncurred	26159000	USD
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	45100000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	37900000	USD
	mho	Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements	7300000	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	19100000	USD
	mho	Distribution Of Single Family Lots From Unconsolidated Llcs DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs	11500000	USD
CY2020Q2	mho	Companysinvestmentinjointdevelopmentorsimilaragreements Companysinvestmentinjointdevelopmentorsimilaragreements	42900000	USD
CY2019Q4	mho	Companysinvestmentinjointdevelopmentorsimilaragreements Companysinvestmentinjointdevelopmentorsimilaragreements	35500000	USD
CY2020Q2	mho	Equityinvestedin Ll Cs EquityinvestedinLLCs	2200000	USD
CY2019Q4	mho	Equityinvestedin Ll Cs EquityinvestedinLLCs	2400000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	200000	USD
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	45100000	USD
CY2020Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	1000000.0	USD
CY2020Q2	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	-600000	USD
	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	400000	USD
	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	400000	USD
CY2020Q2	mho	Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments	810000	USD
CY2019Q4	mho	Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments	1445000	USD
CY2020Q2	mho	Notional Amount Of Uncommitted Interest Rate Lock Commitments NotionalAmountOfUncommittedInterestRateLockCommitments	216377000	USD
CY2019Q4	mho	Notional Amount Of Uncommitted Interest Rate Lock Commitments NotionalAmountOfUncommittedInterestRateLockCommitments	87340000	USD
CY2020Q2	mho	Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments	186000000	USD
CY2019Q4	mho	Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments	88000000	USD
CY2020Q2	mho	Best Effort Contracts And Related Mortgage Loans Held For Sale BestEffortContractsAndRelatedMortgageLoansHeldForSale	1043000	USD
CY2019Q4	mho	Best Effort Contracts And Related Mortgage Loans Held For Sale BestEffortContractsAndRelatedMortgageLoansHeldForSale	6125000	USD
CY2020Q2	mho	Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale	154000000	USD
CY2019Q4	mho	Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale	144000000	USD
CY2020Q2	mho	Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities	157345000	USD
CY2019Q4	mho	Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities	144411000	USD
CY2020Q2	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	1177000	USD
CY2019Q2	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	253000	USD
	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	773000	USD
	mho	Gain Loss On Assets And Liabilities Measured On Recurring Basis GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis	796000	USD
CY2020Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020Q2	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	0	USD
CY2020Q2	mho	Total Of Loans Covered By Guarantees TotalOfLoansCoveredByGuarantees	17100000	USD
CY2019Q4	mho	Total Of Loans Covered By Guarantees TotalOfLoansCoveredByGuarantees	48100000	USD
CY2020Q2	mho	Total Of Guaranteed Loans Inquired About TotalOfGuaranteedLoansInquiredAbout	600000	USD
CY2020Q2	mho	Total Loans Indemnified TotalLoansIndemnified	600000	USD
CY2019Q4	mho	Total Loans Indemnified TotalLoansIndemnified	1000000.0	USD
CY2020Q2	mho	Loan Repurchase Guarantee Liability LoanRepurchaseGuaranteeLiability	500000	USD
CY2020Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	26040000	USD
CY2019Q1	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25220000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	7264000	USD
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	8201000	USD
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	26420000	USD
CY2018Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	26459000	USD
CY2020Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	4242000	USD
CY2019Q2	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	3641000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	7663000	USD
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	6481000	USD
CY2020Q2	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-623000	USD
CY2019Q2	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	557000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-644000	USD
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	735000	USD
CY2020Q2	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	0	USD
CY2019Q2	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	0	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	0	USD
	us-gaap	Product Warranty Accrual Period Increase Decrease ProductWarrantyAccrualPeriodIncreaseDecrease	0	USD
CY2020Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3484000	USD
CY2019Q2	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	3944000	USD
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	26175000	USD
CY2019Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25474000	USD
CY2020Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	26175000	USD
CY2019Q2	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	25474000	USD
CY2020Q2	mho	Stucco Repair Cost StuccoRepairCost	500000	USD
CY2020Q2	us-gaap	Insurance Recoveries InsuranceRecoveries	500000	USD
CY2020Q2	mho	Estimated Repair Costsfor Affected Homes EstimatedRepairCostsforAffectedHomes	4000000.0	USD
CY2020Q2	mho	Letters Of Credit And Bonds LettersOfCreditAndBonds	256000000.0	USD
CY2020Q2	mho	Outstanding Performance Bonds OutstandingPerformanceBonds	180500000	USD
CY2020Q2	mho	Performance Letters Of Credit Outstanding PerformanceLettersOfCreditOutstanding	56300000	USD
CY2020Q2	mho	Financial Letters Of Credit FinancialLettersOfCredit	13200000	USD
CY2020Q2	mho	Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Contracts OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionContracts	12700000	USD
CY2020Q2	mho	Financial Bonds FinancialBonds	6000000.0	USD
CY2020Q2	us-gaap	Purchase Options Land PurchaseOptionsLand	715700000	USD
CY2020Q2	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1400000	USD
CY2019Q4	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	700000	USD
CY2020Q1	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	599800000	USD
CY2020Q2	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	749700000	USD
CY2020Q2	us-gaap	Debt Instrument Unused Borrowing Capacity Amount DebtInstrumentUnusedBorrowingCapacityAmount	716300000	USD
CY2020Q2	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2020Q2	mho	Letters Of Credit Outstanding Under Credit Facility LettersOfCreditOutstandingUnderCreditFacility	69500000	USD
CY2020Q2	us-gaap	Line Of Credit Facility Remaining Borrowing Capacity LineOfCreditFacilityRemainingBorrowingCapacity	430500000	USD
CY2020Q2	mho	Maximum Borrowing Availability Under All Credit Lines MaximumBorrowingAvailabilityUnderAllCreditLines	190000000.0	USD
CY2019Q4	mho	Maximum Borrowing Availability Under All Credit Lines MaximumBorrowingAvailabilityUnderAllCreditLines	225000000.0	USD
CY2020Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	134200000	USD
CY2019Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	136900000	USD
CY2020Q2	us-gaap	Equity Restrictions EquityRestrictions	299300000	USD
CY2019Q4	us-gaap	Equity Restrictions EquityRestrictions	264500000	USD
CY2020Q2	us-gaap	Other Notes Payable OtherNotesPayable	7000000.0	USD
CY2019Q4	us-gaap	Other Notes Payable OtherNotesPayable	5800000	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	54508000	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	30246000	USD
	us-gaap	Net Income Loss NetIncomeLoss	86254000	USD
	us-gaap	Net Income Loss NetIncomeLoss	47969000	USD
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28531000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27599000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28504000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27549000	shares
CY2020Q2	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	115000	shares
CY2019Q2	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	308000	shares
	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	210000	shares
	mho	Incremental Common Shares Attributable To Stock Options IncrementalCommonSharesAttributableToStockOptions	276000	shares
CY2020Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	190000	shares
CY2019Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	183000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	206000	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	202000	shares
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28836000	shares
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28090000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28920000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28027000	shares
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.91
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.10
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	3.03
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.74
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.89
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.98
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.71
CY2020Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1178000	shares
CY2019Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	412000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	676000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	714000	shares
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17200000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000000.0	USD
CY2020Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.240	Rate
CY2019Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.266	Rate
CY2020Q2	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26800000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16700000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.237	Rate
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.258	Rate
	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	1200000	USD
	us-gaap	Proceeds And Excess Tax Benefit From Sharebased Compensation ProceedsAndExcessTaxBenefitFromSharebasedCompensation	400000	USD
CY2020Q2	us-gaap	Revenues Revenues	714194000	USD
CY2019Q2	us-gaap	Revenues Revenues	623686000	USD
	us-gaap	Revenues Revenues	1291797000	USD
	us-gaap	Revenues Revenues	1104795000	USD
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	74239000	USD
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	46213000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	120243000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	76605000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	2515000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	5197000	USD
	us-gaap	Interest Expense InterestExpense	7215000	USD
	us-gaap	Interest Expense InterestExpense	11989000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	187000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	55000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	66000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71727000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41203000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	113083000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	64682000	USD
CY2020Q2	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	32988000	USD
CY2020Q2	mho	Inventory Segments InventorySegments	1797822000	USD
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	45144000	USD
CY2020Q2	mho	Other Combined Assets OtherCombinedAssets	451754000	USD
CY2020Q2	us-gaap	Assets Assets	2327708000	USD
CY2019Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	28532000	USD
CY2019Q4	mho	Inventory Segments InventorySegments	1740975000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	37885000	USD
CY2019Q4	mho	Other Combined Assets OtherCombinedAssets	298202000	USD
CY2019Q4	us-gaap	Assets Assets	2105594000	USD
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	32800000	USD
CY2020Q2	us-gaap	Revenues Revenues	714194000	USD
CY2020Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	557791000	USD
CY2020Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	41037000	USD
CY2020Q2	us-gaap	Selling Expense SellingExpense	41127000	USD
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000	USD
CY2020Q2	us-gaap	Interest Expense InterestExpense	2515000	USD
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	642467000	USD
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	71727000	USD
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	17219000	USD
CY2020Q2	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	54508000	USD
CY2019Q2	us-gaap	Revenues Revenues	623686000	USD
CY2019Q2	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	503857000	USD
CY2019Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36164000	USD
CY2019Q2	us-gaap	Selling Expense SellingExpense	37452000	USD
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	187000	USD
CY2019Q2	us-gaap	Interest Expense InterestExpense	5197000	USD
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	582483000	USD
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	41203000	USD
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10957000	USD
CY2019Q2	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	30246000	USD
	us-gaap	Revenues Revenues	1291797000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1018715000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	74884000	USD
	us-gaap	Selling Expense SellingExpense	77955000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	55000	USD
	us-gaap	Interest Expense InterestExpense	7215000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1178714000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	113083000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	26829000	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	86254000	USD
	us-gaap	Revenues Revenues	1104795000	USD
CY2020Q2	mho	Seniornotesdue2025 Seniornotesdue2025	247353000	USD
CY2020Q2	mho	Seniornotesdue2028 Seniornotesdue2028	394174000	USD
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	892324000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66863000	USD
	us-gaap	Selling Expense SellingExpense	69003000	USD
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	66000	USD
	us-gaap	Interest Expense InterestExpense	11989000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	1040113000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	64682000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16713000	USD
	us-gaap	Income Loss From Subsidiaries Net Of Tax IncomeLossFromSubsidiariesNetOfTax	0	USD
	us-gaap	Net Income Loss NetIncomeLoss	47969000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94023000	USD
CY2020Q2	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	163536000	USD
CY2020Q2	us-gaap	Inventory Real Estate InventoryRealEstate	1830810000	USD
CY2020Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21004000	USD
CY2020Q2	us-gaap	Equity Method Investments EquityMethodInvestments	45144000	USD
CY2020Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	51193000	USD
CY2020Q2	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9378000	USD
CY2020Q2	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2020Q2	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2020Q2	us-gaap	Goodwill Goodwill	16400000	USD
CY2020Q2	us-gaap	Other Assets OtherAssets	96220000	USD
CY2020Q2	us-gaap	Assets Assets	2327708000	USD
CY2020Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	169088000	USD
CY2020Q2	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	49529000	USD
CY2020Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	51193000	USD
CY2020Q2	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2020Q2	us-gaap	Other Liabilities OtherLiabilities	158146000	USD
CY2020Q2	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	11560000	USD
CY2020Q2	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	11035000	USD
CY2020Q2	us-gaap	Line Of Credit LineOfCredit	0	USD
CY2020Q2	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	134184000	USD
CY2020Q2	us-gaap	Other Notes Payable OtherNotesPayable	7041000	USD
CY2020Q2	us-gaap	Liabilities Liabilities	1233303000	USD
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	1094405000	USD
CY2020Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2327708000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6083000	USD
CY2019Q4	us-gaap	Loans Receivable Held For Sale Net Not Part Of Disposal Group LoansReceivableHeldForSaleNetNotPartOfDisposalGroup	155244000	USD
CY2019Q4	us-gaap	Inventory Real Estate InventoryRealEstate	1769507000	USD
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22118000	USD
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	37885000	USD
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18415000	USD
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	9631000	USD
CY2019Q4	us-gaap	Investments In Affiliates Subsidiaries Associates And Joint Ventures InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures	0	USD
CY2019Q4	us-gaap	Due From Affiliates DueFromAffiliates	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	16400000	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	70311000	USD
CY2019Q4	us-gaap	Assets Assets	2105594000	USD
CY2019Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	125026000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6083000	USD
CY2019Q4	us-gaap	Customer Advances And Deposits CustomerAdvancesAndDeposits	34462000	USD
CY2019Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0	USD
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	18415000	USD
CY2019Q4	us-gaap	Other Liabilities OtherLiabilities	147937000	USD
CY2019Q4	us-gaap	Special Assessment Bond Noncurrent SpecialAssessmentBondNoncurrent	13531000	USD
CY2019Q4	mho	Obligation For Consolidated Inventory Not Owned ObligationForConsolidatedInventoryNotOwned	7934000	USD
CY2019Q4	us-gaap	Line Of Credit LineOfCredit	66000000	USD
CY2019Q4	us-gaap	Warehouse Agreement Borrowings WarehouseAgreementBorrowings	136904000	USD
CY2019Q4	us-gaap	Other Notes Payable OtherNotesPayable	5828000	USD
CY2019Q4	mho	Seniornotesdue2021 Seniornotesdue2021	298988000	USD
CY2019Q4	mho	Seniornotesdue2025 Seniornotesdue2025	247092000	USD
CY2019Q4	us-gaap	Liabilities Liabilities	1102117000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	1003477000	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2105594000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	82826000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1976000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	363000	USD
	mho	Intercompany Investing IntercompanyInvesting	0	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	19089000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-20702000	USD
	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	300000000	USD
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	400000000	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	306800000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	372800000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-2720000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	1213000	USD
	mho	Intercompany Financing IntercompanyFinancing	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1912000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	8410000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3645000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	25816000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	87940000	USD
CY2020Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	94023000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	10617000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1599000	USD
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	150000	USD
	mho	Intercompany Investing IntercompanyInvesting	0	USD
	us-gaap	Payments To Acquire Interest In Subsidiaries And Affiliates PaymentsToAcquireInterestInSubsidiariesAndAffiliates	15281000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16730000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	5150000	USD
	us-gaap	Payments Of Dividends PaymentsOfDividends	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	40000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3277000	USD
	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	374500000	USD
	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	317600000	USD
	us-gaap	Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess	-49165000	USD
	us-gaap	Proceeds From Repayments Of Other Debt ProceedsFromRepaymentsOfOtherDebt	-845000	USD
	mho	Intercompany Financing IntercompanyFinancing	0	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4977000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1136000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21529000	USD
CY2019Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20393000	USD
CY2020Q2	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	100000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1900000	USD
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	1400000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	32800000	USD
CY2020Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	17200000	USD
CY2020Q2	us-gaap	Revenues Revenues	714194000	USD
CY2019Q2	us-gaap	Revenues Revenues	623686000	USD
	us-gaap	Revenues Revenues	1291797000	USD
	us-gaap	Revenues Revenues	1104795000	USD
CY2020Q2	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	-7000000.0	USD
CY2019Q2	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	-2600000	USD
	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	-10600000	USD
	us-gaap	Gain Loss On Oil And Gas Hedging Activity GainLossOnOilAndGasHedgingActivity	-6000000.0	USD
CY2020Q2	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	-600000	USD
CY2020Q1	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	1000000.0	USD
CY2020Q2	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	-600000	USD
	us-gaap	Mortgage Servicing Rights Msr Impairment Recovery MortgageServicingRightsMSRImpairmentRecovery	400000	USD

Files In Submission

Name	View Source	Status
0000799292-20-000081-index-headers.html	Edgar Link	pending
0000799292-20-000081-index.html	Edgar Link	pending
0000799292-20-000081.txt	Edgar Link	pending
0000799292-20-000081-xbrl.zip	Edgar Link	pending
exhibit311ceocertifica.htm	Edgar Link	pending
exhibit312cfocertifica.htm	Edgar Link	pending
exhibit321ceocertifica.htm	Edgar Link	pending
exhibit322cfocertifica.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mho-20200630.htm	Edgar Link	pending
mho-20200630.xsd	Edgar Link	pending
mho-20200630_cal.xml	Edgar Link	unprocessable
mho-20200630_def.xml	Edgar Link	unprocessable
mho-20200630_htm.xml	Edgar Link	completed
mho-20200630_lab.xml	Edgar Link	unprocessable
mho-20200630_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MHO
M/I HOMES, INC. Stock $mho

2020 Q2 Form 10-Q Financial Statement

#000079929220000081 Filed on July 31, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHO M/I HOMES, INC. Stock $mho

2020 Q2 Form 10-Q Financial Statement

#000079929220000081 Filed on July 31, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MHO
M/I HOMES, INC. Stock $mho